
What smart money is saying about iRhythm Technologies
1 fund in our archive has pitched iRhythm Technologies — most recently Granahan Investment Management Small Cap Select in June 2026.
iRhythm Technologies, Inc. is a digital healthcare enterprise dedicated to offering portable electrocardiogram (ECG) monitoring solutions to individuals in the United States who face the risk of cardiac arrhythmias. Its primary offering, the Zio service, provides a comprehensive ambulatory cardiac monitoring system. This system ingeniously combines a wireless, patch-based, and wearable biosensor—specifically embodied in products like the Zio XT and AT monitors—with a sophisticated cloud-based data analysis platform. These single-use biosensors precisely record a patient's heartbeats and ECG data, thereby enabling medical professionals to effectively oversee patient heart health and accurately diagnose arrhythmias. Furthermore, iRhythm maintains a strategic development partnership with Verily Life Sciences LLC, focused on pioneering future atrial fibrillation screening, detection, and monitoring innovations. Founded in 2006, the company maintains its corporate headquarters in San Francisco, California.
Get an email when a fund buys, sells or pitches it
Position history
Between Q3 2025 and Q2 2026, 2 fund letters reported a position in iRhythm Technologies, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 0 | 0 | 0 | 1 |
| Q3 2025 | 2 | 0 | 0 | 0 |
Fund activity · 2 positions
- September 2025
“Within medical devices, iRhythm is driving growth for its unique technology after years of foundational investments.”
iRhythm Technologies - September 2025
“Within medical devices, iRhythm and Insulet are driving growth for their unique technologies after years of foundational investments.”
iRhythm Technologies
Fund coverage · 1 thesis
iRhythm Technologies leads ambulatory cardiac monitoring with differentiated AI-enabled technology and multiple growth catalysts.
Read the full thesis
Read every full thesis on iRhythm Technologies
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→